Kinnevik (KINV) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
16 Apr, 2026Executive summary
Net asset value (NAV) declined 22% in Q1 2026 to SEK 27.9bn, driven by macroeconomic headwinds, public market de-rating, AI disruption risks, and challenges in Climate Tech.
Interim CEO Rubin Ritter appointed in March 2026, focusing on stewardship, performance culture, and organizational simplification, with a search for a permanent CEO ongoing.
Discontinued new investments in Climate Tech and removed 'core companies' reporting, shifting focus to Healthcare & Bio, Software, and select emerging companies.
Organizational restructuring and cost review underway, targeting SEK 200 million annual management cash cost by 2027, down from SEK 313 million in 2025 (35% reduction).
SEK 5 billion in discretionary investment capacity preserved for future opportunities, with no current share buybacks planned.
Financial highlights
NAV per share fell to SEK 101 at Q1 2026 close, with a net loss of SEK 7,969m in the quarter.
Private portfolio value decreased by 29%, with Health & Bio down 20%, Software down 38%, and Climate Tech down 56%.
SEK 8.3 billion negative impact on private valuations due to multiple contraction.
Net investments in Q1 were SEK 116 million, mainly from participation in Mews's funding round and a real estate sale.
Net cash balance remained stable at SEK 7.5 billion at quarter-end.
Outlook and guidance
Management expects to reach the new cost target by 2027, with most restructuring costs incurred in 2026.
SEK 1.5 billion cap set for follow-on investments in the existing portfolio over the next five years.
Focus remains on preserving cash for future strategic flexibility and potential new investments; no share buybacks planned.
Latest events from Kinnevik
- AI-driven derating and macro uncertainty caused sharp valuation drops across key portfolio sectors.KINV
Pre-silent presentation7 Apr 2026 - NAV fell 4% in Q4 and 8% for 2025 as market headwinds offset strong core company growth.KINV
Q4 20253 Feb 2026 - NAV fell 4.7–5% as core growth companies outperformed and capital deployment set to rise.KINV
Q2 20243 Feb 2026 - Strong portfolio growth offset by 15–20% valuation headwinds from market and currency shifts.KINV
Pre-silent presentation26 Jan 2026 - NAV fell 5% to SEK 37.4bn as VillageMD was written down, but core assets grew over 60%.KINV
Q3 202419 Jan 2026 - Focused on high-growth private assets in health, software, and climate tech, targeting 15–25%+ returns.KINV
CMD 202419 Jan 2026 - NAV up 5% to SEK 39.2bn, core companies grew 55%, strong SEK 10.9bn net cash for growth.KINV
Q4 20249 Jan 2026 - NAV up 2% to SEK 36.8bn, core revenue growth >35%, SEK 860m invested, SEK 9.6bn net cash.KINV
Q2 20258 Jan 2026 - NAV down 8% as core companies delivered >40% revenue growth and strong cash position.KINV
Q1 202524 Dec 2025